Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
SBIO
92
HOLDINGS
23%
ALSO IN BBP
BBP
65
HOLDINGS
31%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
RHYTHM PHARMACEUTICALS, INC. | 3.6% | 3.0% | 3.0% |
|
AXSOME THERAPEUTICS, INC. | 3.1% | 2.2% | 2.2% |
|
PTC THERAPEUTICS INC | 2.4% | 2.0% | 2.0% |
|
MIRUM PHARMACEUTICALS, INC. | 1.9% | 3.0% | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.9% | 2.4% | 1.9% |
SBIO Overweight Relative to BBP
|
AVIDITY BIOSCIENCES INC | 3.3% |
|
CYTOKINETICS INC | 3.1% |
|
NUVALENT, INC. CLASS A | 2.8% |
 |
MERUS N.V. | 2.7% |
|
CRINETICS PHARMACEUTICALS INC | 2.4% |
 |
ALKERMES PLC | 2.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 2.4% |
|
VAXCYTE, INC. | 2.3% |
|
ARCELLX, INC. | 2.2% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.2% |
SBIO Underweight Relative to BBP
|
INSMED INC | -3.3% |
|
BRIDGEBIO PHARMA, INC. | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.0% |
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
HALOZYME THERAPEUTICS INC | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |